Patent · US Active

Nano-scale contrast agents and methods of use

US8357351B2 · kind B2 · utility

6Cited by

22References

23Claims

0Family size

Inventors

Ananth Annapragada · Manvel, US
Efstathios Karathanasis · Atlanta, US
Ravi V. Bellamkonda · Atlanta, US
Russell M. Lebovitz · San Diego, US

Key dates

Filing date	Jan 22, 2009
Grant date	Jan 22, 2013
Priority date	—
Expiry date	Aug 2, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K49/0438
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compositions and methods are disclosed for evaluating a subject's vasculature integrity, for differentiating between a malignant lesion and a benign lesion, for evaluating the accessibility of a tumor to nano-sized therapeutics, for treating tumors, and for live or real time monitoring of a nano-probe's biodistribution.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.